Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 19(2): e0294307, 2024.
Article in English | MEDLINE | ID: mdl-38412191

ABSTRACT

OBJECTIVE: The unprecedented events of 2020 required a pivot in scientific training to better prepare the biomedical research workforce to address global pandemics, structural racism, and social inequities that devastate human health individually and erode it collectively. Furthermore, this pivot had to be accomplished in the virtual environment given the nation-wide lockdown. METHODS: These needs and context led to leveraging of the San Francisco Building Infrastructure Leading to Diversity (SF BUILD) theories of change to innovate a Virtual BUILD Research Collaboratory (VBRC). The purpose of VBRC was to train Black, Indigenous, and people of color (BIPOC) students to apply their unique perspectives to biomedical research. These training activities were evaluated using a pre-post survey design that included both validated and new psychosocial scales. A new scale was piloted to measure culturally relevant pedagogy. RESULTS: VBRC scholars increased science identity on two items: thinking of myself as a scientist (+1point, p = 0.006) and belonging to a community of scientists (+1point, p = 0.069). Overall, scholars perceived stress also decreased over VBRC (-2.35 points, p = 0.02). Post VBRC, scholars had high agency scores (µ = 11.02, Md = 12, range = 6-12, σ = 1.62) and cultural humility scores (µ = 22.11, Md = 23, range = 12-24, σ = 2.71). No notable race/ethnic differences were found in any measures. CONCLUSIONS: Taken together, our innovative approach to data science training for BIPOC in unprecedented times shows promise for better preparing the workforce critically needed to address the fundamental gaps in knowledge at the intersection of public health, structural racism, and biomedical sciences.


Subject(s)
Biomedical Research , Racism , Humans , Racism/prevention & control , Data Science , Workforce , Biomedical Research/education , Students
2.
PLoS One ; 17(9): e0274100, 2022.
Article in English | MEDLINE | ID: mdl-36137156

ABSTRACT

BACKGROUND: The lack of race/ethnic and gender diversity in grants funded by the National Institutes of Health (NIH) is a persistent challenge related to career advancement and the quality and relevance of health research. We describe pilot programs at nine institutions supported by the NIH-sponsored Building Infrastructure Leading to Diversity (BUILD) program aimed at increasing diversity in biomedical research. METHODS: We collected data from the 2016-2017 Higher Education Research Institute survey of faculty and NIH progress reports for the first four years of the program (2015-2018). We then conducted descriptive analyses of data from the nine BUILD institutions that had collected data and evaluated which activities were associated with research productivity. We used Poisson regression and rate ratios of the numbers of BUILD pilots funded, students included, abstracts, presentations, publications, and submitted and funded grant proposals. RESULTS: Teaching workshops were associated with more abstracts (RR 4.04, 95% CI 2.21-8.09). Workshops on grant writing were associated with more publications (RR 2.64, 95% CI 1.64-4.34) and marginally with marginally more presentations. Incentives to develop courses were associated with more abstracts published (RR 4.33, 95% CI 2.56-7.75). Workshops on research skills and other incentives were not associated with any positive effects. CONCLUSIONS: Pilot interventions show promise in supporting diversity in NIH-level research. Longitudinal modeling that considers time lags in career development in moving from project development to grants submissions can provide more direction for future diversity pilot interventions.


Subject(s)
Biomedical Research , Financing, Organized , Academies and Institutes , Humans , National Institutes of Health (U.S.) , United States , Writing
4.
J Am Chem Soc ; 138(22): 7130-42, 2016 06 08.
Article in English | MEDLINE | ID: mdl-27232659

ABSTRACT

We describe the isolation, structure elucidation, and total synthesis of the novel marine natural product rifsaliniketal and the total synthesis of the structurally related variants salinisporamycin and saliniketals A and B. Rifsaliniketal was previously proposed, but not observed, as a diverted metabolite from a biosynthetic precursor to rifamycin S. Decarboxylation of rifamycin provides salinisporamycin, which upon truncation with loss of the naphthoquinone ring leads to saliniketals. Our synthetic strategy hinged upon a Pt(II)-catalyzed cycloisomerization of an alkynediol to set the dioxabicyclo[3.2.1]octane ring system and a fragmentation of an intermediate dihydropyranone to forge a stereochemically defined (E,Z)-dienamide unit. Multiple routes were explored to assemble fragments with high stereocontrol, an exercise that provided additional insights into acyclic stereocontrol during stereochemically complex fragment-assembly processes. The resulting 11-14 step synthesis of saliniketals then enabled us to explore strategies for the synthesis and coupling of highly substituted naphthoquinones or the corresponding naphthalene fragments. Whereas direct coupling with naphthoquinone fragments proved unsuccessful, both amidation and C-N bond formation tactics with the more electron-rich naphthalene congeners provided an efficient means to complete the first total synthesis of rifsaliniketal and salinisporamycin.


Subject(s)
Bridged Bicyclo Compounds, Heterocyclic/chemical synthesis , Chemistry Techniques, Synthetic/methods , Rifamycins/chemical synthesis , Bridged Bicyclo Compounds, Heterocyclic/chemistry , Decarboxylation , Hydrogen Bonding , Micromonosporaceae/metabolism , Molecular Structure , Naphthalenes/chemistry , Naphthoquinones/chemistry , Rifamycins/biosynthesis , Rifamycins/chemistry
5.
Sci Signal ; 6(297): ra90, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-24129700

ABSTRACT

A challenge for biomedical research is the development of pharmaceuticals that appropriately target disease mechanisms. Natural products can be a rich source of bioactive chemicals for medicinal applications but can act through unknown mechanisms and can be difficult to produce or obtain. To address these challenges, we developed a new marine-derived, renewable natural products resource and a method for linking bioactive derivatives of this library to the proteins and biological processes that they target in cells. We used cell-based screening and computational analysis to match gene expression signatures produced by natural products to those produced by small interfering RNA (siRNA) and synthetic microRNA (miRNA) libraries. With this strategy, we matched proteins and miRNAs with diverse biological processes and also identified putative protein targets and mechanisms of action for several previously undescribed marine-derived natural products. We confirmed mechanistic relationships for selected siRNAs, miRNAs, and compounds with functional roles in autophagy, chemotaxis mediated by discoidin domain receptor 2, or activation of the kinase AKT. Thus, this approach may be an effective method for screening new drugs while simultaneously identifying their targets.


Subject(s)
Biological Products/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Gene Ontology , Transcriptome/drug effects , Animals , Autophagy/drug effects , Autophagy/genetics , Bacteria/chemistry , Bacteria/classification , Biological Products/chemistry , Biological Products/isolation & purification , Cell Line, Tumor , Cells, Cultured , Cluster Analysis , Computational Biology/methods , Drug Evaluation, Preclinical/methods , Gene Regulatory Networks/drug effects , Gene Regulatory Networks/genetics , HCT116 Cells , Humans , Invertebrates/chemistry , MCF-7 Cells , Marine Biology , Mice , Mice, Inbred BALB C , MicroRNAs/genetics , Molecular Structure , Oligonucleotide Array Sequence Analysis , RNA Interference
6.
Proc Natl Acad Sci U S A ; 110(4): 1303-8, 2013 Jan 22.
Article in English | MEDLINE | ID: mdl-23297231

ABSTRACT

The polyketide natural product Leptomycin B inhibits nuclear export mediated by the karyopherin protein chromosomal region maintenance 1 (CRM1). Here, we present 1.8- to 2.0-Å-resolution crystal structures of CRM1 bound to Leptomycin B and related inhibitors Anguinomycin A and Ratjadone A. Structural and complementary chemical analyses reveal an unexpected mechanism of inhibition involving covalent conjugation and CRM1-mediated hydrolysis of the natural products' lactone rings. Furthermore, mutagenesis reveals the mechanism of hydrolysis by CRM1. The nuclear export signal (NES)-binding groove of CRM1 is able to drive a chemical reaction in addition to binding protein cargoes for transport through the nuclear pore complex.


Subject(s)
Active Transport, Cell Nucleus/drug effects , Karyopherins/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Acrylates/chemistry , Acrylates/pharmacology , Amino Acid Substitution , Crystallography, X-Ray , Fatty Acids, Unsaturated/chemistry , Fatty Acids, Unsaturated/metabolism , Fatty Acids, Unsaturated/pharmacology , Humans , Hydrolysis , Karyopherins/antagonists & inhibitors , Karyopherins/chemistry , Karyopherins/genetics , Models, Anatomic , Mutagenesis, Site-Directed , Nuclear Export Signals/genetics , Protein Conformation , Receptors, Cytoplasmic and Nuclear/antagonists & inhibitors , Receptors, Cytoplasmic and Nuclear/chemistry , Receptors, Cytoplasmic and Nuclear/genetics , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Static Electricity , Triazoles/chemistry , Triazoles/pharmacology , Exportin 1 Protein
7.
Cell Biol Toxicol ; 27(3): 159-68, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21069563

ABSTRACT

In this report, we have tested the cytotoxicity of two organotin (OT) compounds by flow cytometry on a panel of immortalized cancer cell lines of human and murine origin. Although the OT compounds exhibited varying levels of cytotoxicity, diphenylmethyltin chloride was more toxic than 1,4-bis (diphenylchlorostannyl)p-xylene on all cell lines tested. The OT compounds were found to be highly cytotoxic to lymphoma cell lines with lower toxicity toward the HeLa cervical cancer cell line. In order to discern the mechanism by which cell death was induced, additional experiments were conducted to monitor characteristic changes consistent with apoptosis and/or necrosis. Cell lines treated with the experimental compounds indicated that there was no consistent mode of cell death induction. However, both compounds induced apoptosis in the pro-B lymphocyte cell line, NFS-70. The work presented here also demonstrates that the two OT compounds possess selective cytotoxicity against distinct transformed cell lines.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Organotin Compounds/pharmacology , Animals , Annexin A5/metabolism , Antineoplastic Agents/toxicity , Cell Line, Tumor , Drug Screening Assays, Antitumor , Flow Cytometry , Humans , Inhibitory Concentration 50 , Intercalating Agents , Mice , Necrosis , Organotin Compounds/toxicity , Propidium , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...